Suit the Remedy to the Case: An Activatable DNA Damage Initiator for Postsurgical Therapy of Glioblastoma with TP53 Mutations
Abstract
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery · Glioma Diagnosis and Treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, P. R. China
Department of Cell Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing 211166, P. R. China
Wuxi Key Laboratory of Biomaterials for Clinical Application, Key Laboratory for Multidisciplinary Intersection of Radiotherapy and Immunology for Gastrointestinal Tumor, Department of Central Laboratory, Jiangyin Clinical College of Xuzhou Medical University, Wuxi 214400, P. R. China
Department of General Surgery, Jiangyin Clinical College of Xuzhou Medical University, Wuxi 214400, P. R. China
Department of Neurosurgery, Jiangyin Clinical College of Xuzhou Medical University, Wuxi 214400, P. R. China
Funding
Wuxi Health and Family Planning Commission · Natural Science Foundation of Jiangsu Province · National Natural Science Foundation of China · Affiliated Hospital Development Foundation of Xuzhou Medical University